Amgen, Inc. (AMGN), Pharmasset (VRUS), Vitamin Shoppe (VSI), Altera (ALTR), AMC Networks (AMCX) and Autonation Inc. (AN) ratings and price targets.
BMO Capital Markets downgraded Amgen, Inc. (AMGN) from an
“Outperform” rating to a “Market Perform” rating. They have a price target of $58.00 on the company.
UBS AG (NYSE:UBS) downgraded Pharmasset (VRUS) from a “Buy” rating to a “Neutral” rating.
Piper Jaffray (NYSE:PJC) reiterated its “Overweight” on Vitamin Shoppe (VSI).
Lazard Capital initiated coverage on Altera (ALTR). They placed a “Buy” rating and a price target of $45.00 on the company.
Morgan Stanley (NYSE:MS) raised its price target on AMC Networks (AMCX) to $37.00.
Goldman Sachs (NYSE:GS) upgraded Autonation Inc. (AN) from a “Sell” rating to a “Neutral” rating.
Tuesday, November 22, 2011
Amgen (AMGN) (VRUS) (VSI) (ALTR) (AMCX) (AN) Ratings, Price Targets
Labels:
Goldman Sachs
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment